Mycophenolate Mofetil and Prednisolone Therapy in Children with Steroid-Dependent Nephrotic Syndrome

American Journal of Kidney Diseases

Volumn 42, Issue 6, 2003, Pages 1114-1120

  Bagga, Arvind ^a   Hari, Pankaj ^b   Moudgil, Asha ^b   Jordan, Stanley C ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Focal segmental glomerulo sclerosis (FSGS); Minimal change disease; Mycophenolate mofetil (MMF); Prednisolone

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ABDOMINAL PAIN; AGE; ARTICLE; BLOOD TOXICITY; CELLULITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL TOXICITY; HEPATITIS; HUMAN; INFECTION; KIDNEY BIOPSY; LEUKOPENIA; LONG TERM CARE; MALE; NEPHROTIC SYNDROME; PERITONITIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; RELAPSE; REMISSION; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0344827163     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2003.08.011     Document Type: Article

References (19)

1. Srivastava RN, Bagga A: Nephrotic syndrome, in Srivastava RN, Bagga A (eds): Pediatric Nephrology (ed 3). New Delhi, India, Jaypee, 2001, pp 128-157
2. Latta K, von Schnakenburg C, Ehrich JH: A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271-282, 2001
3. Bagga A, Sharma A, Srivastava RN: Levamisole therapy in corticosteroid-dependent nephrotic syndrome. Pediatr Nephrol 11:415-417, 1997
4. Durkan AM, Hodson EM, Willis NS, Craig JC: Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trials. Kidney Int 59:1919-1927, 2001
5. Iijima K, Hamahira K, Tanaka R, et al: Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61: 1801-1805, 2002
6. Briggs WA, Choi MJ, Scheel PJ Jr: Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 31:213-217, 1998
7. Mason PD: Minimal change disease and primary focal segmental glomerulosclerosis, in Johnson RJ, Feehally J (eds): Comprehensive Clinical Nephrology. London, UK, Mosby, 2000, pp 22.1-22.10
8. Choi MJ, Eustace JA, Gimenez LF, et al: Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 61:1098-1114, 2002
9. Chandra M, Susin M, Abitbol C: Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil. Pediatr Nephrol 14:224-226, 2000
10. Indian Pediatric Nephrology Group: Indian Academy of Pediatrics: Consensus statement on management of steroid sensitive nephrotic syndrome. Indian Pediatr 38:975-986, 2001
11. Bagga A, Hari P, Srivastava RN: Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol 13:824-827, 1999
12. National Center for Health Statistics, Centers for Disease Control: NCHS Growth Curves for Children: Birth-18 years. Series 11, 165. DHEW publication (PHS) 78 1650, Washington, DC, US Government Printing Office, 1978
13. Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D: Mycophenolate mofetil in the treatment of resistant nephrotic syndrome. Nephrol Dial Transplant 17: 2011-2013, 2002
14. Chan TM, Li FK, Tang CSO, et al: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343:1156-1162, 2000
15. Nowack R, Gobel U, Klooker P, et al: Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement. J Am Soc Nephrol 10:1965-1971, 1999
16. Miller G, Zimmerman R III, Radhakrishnan J, Appel G: Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 36:250-256, 2000
17. US Renal Transplant Mycophenolate Mofetil Study Group: Mycophenolate mofetil in cadaveric renal transplantation. Am J Kidney Dis 34:296-303, 1999
18. Weber LT, Shipkova M, Lamersdorf T, et al: Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. J Am Soc Nephrol 9:1511-1520, 1998
19. Weber LT, Shipkova M, Armstrong VW, et al: The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: A Report of the German Study Group on Mycophenolate Mofetil Therapy. J Am Soc Nephrol 13:759-768, 2002